Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.7 USD | -1.45% | +3.63% | +56.79% |
06-11 | Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target | MT |
05-29 | Enliven Therapeutics, Inc. Appoints Lori Kunkel to the Committee | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.79% | 1.02B | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- ELVN Stock
- News Enliven Therapeutics, Inc.
- Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing